CDK4/6 Inhibition in Early-Stage Breast Cancer: The New Standard?

Title
CDK4/6 Inhibition in Early-Stage Breast Cancer: The New Standard?
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages JCO.20.02688
Publisher
American Society of Clinical Oncology (ASCO)
Online
2020-09-21
DOI
10.1200/jco.20.02688

Ask authors/readers for more resources

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started